e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Sempresto, Inc.
Sempresto Announces Positive FDA Type B Pre-IND Meeting Response for Smartphone-Integrated Epinephrine Auto-Injector
September 17, 2026
From
Sempresto, Inc.
Via
Business Wire
Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award
August 26, 2026
From
Sempresto, Inc.
Via
Business Wire
Sempresto Featured in Inc. Following Acquisition of Alerje Autoinjector Platform
March 19, 2026
From
Sempresto, Inc.
Via
Business Wire
Thomas Jefferson University and Sempresto, Inc. Announce Strategic Partnership to Advance Smartphone-Integrated Rescue Medication Platform
December 10, 2025
From
Sempresto, Inc.
Via
Business Wire
Sempresto Acquires Alerje’s Autoinjector Platform to Accelerate Commercialization of Smartphone Integrated Rescue Medications
December 04, 2025
From
Sempresto, Inc.
Via
Business Wire
Sempresto Acquires Third Autoinjector Platform to Strengthen Leadership in Smartphone-Integrated Rescue Medication Delivery
November 19, 2025
From
Sempresto, Inc.
Via
Business Wire
Sempresto and Health Alliance Global Partner to Develop a Smart Communication Platform Integrating Patientside Diagnostics and Virtual Care with Rescue Medication Delivery
November 06, 2025
From
Sempresto, Inc.
Via
Business Wire
Thomas Jefferson University and Sempresto, Inc. Announce Exclusive, Worldwide Licensing Agreement for Innovative Smartphone-Integrated Epinephrine Autoinjector
November 04, 2025
From
Sempresto, Inc.
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.